Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

A new pill is helping people with Type 2 diabetes lose weight and lower blood sugar in a phase-three clinical trial.

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

The medication — orforglipron from pharmaceutical giant Eli Lilly — is in the same class ... which can decrease appetite and help the body manage insulin production. Orforglipron is not ...

Eli Lilly shares jumped 15% after a clinical trial ... which regulates appetite, insulin secretion, and blood sugar. While originally developed to treat Type 2 diabetes, GLP-1 drugs have surged ...

Indian diabetic population on Human Mixtard concerned on changes in insulin therapy: Nandita Vijayasimha, Bengaluru Thursday, April 24, 2025, 08:00 Hrs [IST] India’s diabetic po ...

Drugmaker Eli Lilly said Thursday that an experimental ... People who have diabetes can’t make enough insulin, a hormone the pancreas makes to help the body keep blood sugar levels in a certain ...